Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia

ClinicalTrials.gov ID: NCT01095562

Public ClinicalTrials.gov record NCT01095562. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 3:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-126 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an efficacy and safety study evaluating an experimental treatment for cognitive deficits in adults with schizophrenia.

Study identification

NCT ID
NCT01095562
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie (prior sponsor, Abbott)
Industry
Enrollment
207 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
20 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2010
Primary completion
Jul 31, 2011
Completion
Aug 31, 2011
Last update posted
Jun 5, 2018

2010 – 2011

United States locations

U.S. sites
23
U.S. states
9
U.S. cities
22
Facility City State ZIP Site status
Site Reference ID/Investigator# 26267 Cerritos California 90703
Site Reference ID/Investigator# 45320 Costa Mesa California 92626
Site Reference ID/Investigator# 27068 Escondido California 92025
Site Reference ID/Investigator# 52568 Garden Grove California 92845
Site Reference ID/Investigator# 26266 Granada Hills California 91344
Site Reference ID/Investigator# 26388 Oceanside California 92056
Site Reference ID/Investigator# 45315 San Bernardino California 92408
Site Reference ID/Investigator# 26271 San Diego California 92102
Site Reference ID/Investigator# 27045 Santa Ana California 92701
Site Reference ID/Investigator# 45314 Santa Ana California 92705
Site Reference ID/Investigator# 26264 Torrance California 90502
Site Reference ID/Investigator# 27072 Tampa Florida 33613
Site Reference ID/Investigator# 27043 Wichita Kansas 67214
Site Reference ID/Investigator# 26395 Lake Charles Louisiana 70629
Site Reference ID/Investigator# 26268 St Louis Missouri 63118
Site Reference ID/Investigator# 26392 Fresh Meadows New York 11366
Site Reference ID/Investigator# 27073 New York New York 10065
Site Reference ID/Investigator# 26262 Rochester New York 14618
Site Reference ID/Investigator# 27071 Beachwood Ohio 44122
Site Reference ID/Investigator# 36020 Media Pennsylvania 19063
Site Reference ID/Investigator# 28063 Norristown Pennsylvania 19401
Site Reference ID/Investigator# 27070 Sellersville Pennsylvania 18960
Site Reference ID/Investigator# 27069 Dallas Texas 75243

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01095562, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 5, 2018 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01095562 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →